129 related articles for article (PubMed ID: 37929785)
1. Repeat sentinel lymph node surgery for locally recurrent breast cancer after prior mastectomy.
Schulze AK; Hoskin TL; Mrdutt MM; Mutter RW; Hieken TJ
J Surg Oncol; 2024 Mar; 129(3):461-467. PubMed ID: 37929785
[TBL] [Abstract][Full Text] [Related]
2. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
Davis J; Boughey JC; Hoskin TL; Day CN; Cheville JC; Piltin MA; Hieken TJ
Clin Breast Cancer; 2021 Oct; 21(5):458-465. PubMed ID: 33839043
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
[TBL] [Abstract][Full Text] [Related]
4. Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures.
Tokmak H; Kaban K; Muslumanoglu M; Demirel M; Aktan S
World J Surg Oncol; 2014 Jul; 12():205. PubMed ID: 25016393
[TBL] [Abstract][Full Text] [Related]
5. Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients.
Barrio AV; Downs-Canner S; Edelweiss M; Van Zee KJ; Cody HS; Gemignani ML; Pilewskie ML; Plitas G; El-Tamer M; Kirstein L; Capko D; Patil S; Morrow M
Ann Surg Oncol; 2020 May; 27(5):1617-1624. PubMed ID: 31820212
[TBL] [Abstract][Full Text] [Related]
6. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
[TBL] [Abstract][Full Text] [Related]
7. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Kuerer HM; Bowling M; Flippo-Morton TS; Byrd DR; Ollila DW; Julian TB; McLaughlin SA; McCall L; Symmans WF; Le-Petross HT; Haffty BG; Buchholz TA; Nelson H; Hunt KK;
JAMA; 2013 Oct; 310(14):1455-61. PubMed ID: 24101169
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy.
Sekine C; Nakano S; Mibu A; Otsuka M; Oinuma T; Takeyama H
Asian J Surg; 2020 Jan; 43(1):148-153. PubMed ID: 31153730
[TBL] [Abstract][Full Text] [Related]
10. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
[TBL] [Abstract][Full Text] [Related]
11. Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.
Costaz H; Boulle D; Bertaut A; Rouffiac M; Beltjens F; Desmoulins I; Peignaux K; Ladoire S; Causeret S; Loustalot C; Padeano MM; Vincent L; Jankowski C; Arnould L; Coutant C
Bull Cancer; 2022 Mar; 109(3):268-279. PubMed ID: 34838310
[TBL] [Abstract][Full Text] [Related]
12. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures.
Naik AM; Fey J; Gemignani M; Heerdt A; Montgomery L; Petrek J; Port E; Sacchini V; Sclafani L; VanZee K; Wagman R; Borgen PI; Cody HS
Ann Surg; 2004 Sep; 240(3):462-8; discussion 468-71. PubMed ID: 15319717
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
[TBL] [Abstract][Full Text] [Related]
14. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
Han SN; Amant F; Cardonick EH; Loibl S; Peccatori FA; Gheysens O; Sangalli CA; Nekljudova V; Steffensen KD; Mhallem Gziri M; Schröder CP; Lok CAR; Verest A; Neven P; Smeets A; Pruneri G; Cremonesi M; Gentilini O;
Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
[TBL] [Abstract][Full Text] [Related]
15. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
Tadros AB; Moo TA; Stempel M; Zabor EC; Khan AJ; Morrow M
Breast Cancer Res Treat; 2020 Feb; 180(1):197-205. PubMed ID: 31938938
[TBL] [Abstract][Full Text] [Related]
16. Can Axillary Lymph Node Dissection be Omitted in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes Undergoing Mastectomy? A Systematic Review and Meta-Analysis of Real-World Evidence.
Chen F; Li X; Lin X; Chen L; Lin Z; Wu H; Chen J
World J Surg; 2023 Oct; 47(10):2446-2456. PubMed ID: 37249632
[TBL] [Abstract][Full Text] [Related]
17. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence.
Port ER; Garcia-Etienne CA; Park J; Fey J; Borgen PI; Cody HS
Ann Surg Oncol; 2007 Aug; 14(8):2209-14. PubMed ID: 17268882
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
Fan YJ; Li JC; Zhu DM; Zhu HL; Zhao Y; Zhu XB; Wu G; Bai TT
BMC Surg; 2023 Jul; 23(1):209. PubMed ID: 37495945
[TBL] [Abstract][Full Text] [Related]
19. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of non-sentinel lymph node metastasis in breast cancer with 1-2 sentinel lymph node macrometastases underwent total mastectomy: a case-control study.
Huang Z; Wu Z; Zou QQ; Xie YJ; Li LH; Huang YP; Wu FM; Huang D; Pan YH; Yang JR
World J Surg Oncol; 2023 Apr; 21(1):125. PubMed ID: 37024930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
